Evidence map›Paper›PMID 25164012›Full record

ArticleCancer research2014

Zfx facilitates tumorigenesis caused by activation of the Hedgehog pathway.

Colin J Palmer, Jose M Galan-Caridad, Stuart P Weisberg, Liang Lei, Jose M Esquilin, Gist F Croft, Brandon Wainwright, Peter Canoll, David M Owens, Boris Reizis

Abstract read
In one paragraph

Article in Cancer research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Zinc and zinc-containing biomolecules in childhood brain tumors.Journal of molecular medicine (Berlin, Germany) · 2016
    Review
  13. ZFX is a Strong Predictor of Poor Prognosis in Renal Cell Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
  14. Article
  15. New role for ZFX in oncogenesis.Cell cycle (Georgetown, Tex.) · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Colin J PalmerDepartment of Microbiology and Immunology, Columbia University Medical Center, New York, New York.
Jose M Galan-CaridadDepartment of Microbiology and Immunology, Columbia University Medical Center, New York, New York.
Stuart P WeisbergDepartment of Microbiology and Immunology, Columbia University Medical Center, New York, New York.
Liang LeiDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, New York.
Jose M EsquilinDivision of Pediatric Hematology, Columbia University Medical Center, New York, New York.
Gist F CroftDepartments of Pathology, Neurology and Neuroscience, and Project A.L.S./Laboratory for Stem Cell Research, Columbia University Medical Center, New York, New York.
Brandon WainwrightInstitute for Molecular Bioscience, University of Queensland, St. Lucia, Queensland, Australia.
Peter CanollDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, New York.
David M OwensDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, New York. Department of Dermatology, Columbia University Medical Center, New York, New York.
Boris ReizisDepartment of Microbiology and Immunology, Columbia University Medical Center, New York, New York. bvr2101@columbia.edu.
Columbia University Irving Medical Center · USThe University of Queensland · AU

Funding

Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
TRAINING PROGRAM IN HYPERTENSIONT32HL007609 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ADLER, GAIL KURR · 1985 to 2022
$10.2M
Understanding the Biology of Chronic Ulcers: Histological and Molecular Basis...P30AR044535 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BICKERS, DAVID RINSEY · 1997 to 2015
$6.9M
Zfx, A Novel Transcriptional Regulator of HematopoiesisR01HL084353 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REIZIS, BORIS · 2006 to 2014
$3.5M
The Role of White Matter Progenitors in Glioma Formation and ProgressionR01NS066955 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CANOLL, PETER · 2010 to 2014
$1.7M
Stem Cells and Cell Lineage SpecificationT32HD055165 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HOBERT, OLIVER · 2007 to 2011
$1.3M
A cellular basis for age-related impaired tactile acuityR21AG044633 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI OWENS, DAVID M · 2014 to 2015
$434k
NCATS NIH HHS UL1 TR000142NHLBI NIH HHS HL084353NHLBI NIH HHS R01 HL084353NHLBI NIH HHS T32 HL007609NIAMS NIH HHS AR044535NIAMS NIH HHS P30 AR044535NIA NIH HHS R21 AG044633NICHD NIH HHS HD055165NICHD NIH HHS T32 HD055165NINDS NIH HHS NS066955NINDS NIH HHS R01 NS066955
6 · The paper itself

Abstract

The Hedgehog (Hh) signaling pathway regulates normal development and cell proliferation in metazoan organisms, but its aberrant activation can promote tumorigenesis. Hh-induced tumors arise from various tissues and they may be indolent or aggressive, as is the case with skin basal cell carcinoma (BCC) or cerebellar medulloblastoma, respectively. Little is known about common cell-intrinsic factors that control the development of such diverse Hh-dependent tumors. Transcription factor Zfx is required for the self-renewal of hematopoietic and embryonic stem cells, as well as for the propagation of acute myeloid and T-lymphoblastic leukemias. We report here that Zfx facilitates the development of experimental BCC and medulloblastoma in mice initiated by deletion of the Hh inhibitory receptor Ptch1. Simultaneous deletion of Zfx along with Ptch1 prevented BCC formation and delayed medulloblastoma development. In contrast, Zfx was dispensable for tumorigenesis in a mouse model of glioblastoma. We used genome-wide expression and chromatin-binding analysis in a human medulloblastoma cell line to characterize direct, evolutionarily conserved targets of Zfx, identifying Dis3L and Ube2j1 as two targets required for the growth of the human medulloblastoma cells. Our results establish Zfx as a common cell-intrinsic regulator of diverse Hh-induced tumors, with implications for the definition of new therapeutic targets in these malignancies.

Indexed as

AnimalsBasal Cell CarcinomaCarcinogenesisCell Line, TumorCell ProliferationCerebellar NeoplasmsGene Knockout TechniquesHedgehog ProteinsHumansKruppel-Like Transcription FactorsMaleMedulloblastomaMice, KnockoutPatched-1 ReceptorPatched ReceptorsReceptors, Cell SurfaceDIS3L protein, humanHedgehog ProteinsKruppel-Like Transcription FactorsPatched-1 ReceptorPatched ReceptorsPTCH1 protein, humanPtch1 protein, mouseReceptors, Cell SurfaceRibonucleasesUBE2J1 protein, humanUbiquitin-Conjugating Enzymeszinc finger protein, X-linked

Identifiers

PMID25164012
PMCPMC4199880
OpenAlexW2085092487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.